References
- MaluccioMCoveyARecent progress in understanding, diagnosing, and treating hepatocellular carcinomaCA Cancer J Clin201262639439923070690
- LiZZhangHHanJChenYLinHYangTSurface nanopore engineering of 2D MXenes for targeted and synergistic multitherapies of hepatocellular carcinomaAdv Mater20183025e170698129663543
- ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
- RazaASoodGKHepatocellular carcinoma review: current treatment, and evidence-based medicineWorld J Gastroenterol201420154115412724764650
- ByamJRenzJMillisJMLiver transplantation for hepatocellular carcinomaHepatobiliary Surg Nutr201321223024570911
- FrenetteCGishRTargeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implicationsWorld J Gastroenterol201218649850622363115
- ChenZHYuYPZuoZHTargeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide geneNat Biotechnol201735654355028459452
- SanyalAJYoonSKLencioniRThe etiology of hepatocellular carcinoma and consequences for treatmentOncologist201015Suppl 4142221115577
- NegriniSGorgoulisVGHalazonetisTDGenomic instability – an evolving hallmark of cancerNat Rev Mol Cell Biol201011322022820177397
- EzzeldinMBorrego-DiazETahaMRalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC)Mol Oncol2014851043105324785097
- HagelMMiduturuCSheetsMFirst selective small molecule inhibitor of fgfr4 for the treatment of hepatocellular carcinomas with an activated FGFR4 signaling pathwayCancer Discov20155442443725776529
- YueXAiJXuYPolymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinomaHepatology20176561948196228073159
- DelireBStärkelPThe Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implicationsEur J Clin Invest201545660962325832714
- LiuYSongCNiHUBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B related hepatocellular carcinomaJ Viral Hepat201825111363137129969176
- HanHHQiuYJShiYYGlypican-3-targeted precision diagnosis of hepatocellular carcinoma on clinical sections with a supramolecular 2D imaging probeTheranostics20188123268327429930728
- TsuchiyaNSawadaYEndoISaitoKUemuraYNakatsuraTBiomarkers for the early diagnosis of hepatocellular carcinomaWorld J Gastroenterol20152137105731058326457017
- SangLWangXMXuDYZhaoWJBioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinomaWorld J Gastroenterol201824242605261629962817
- JiFZhangZHZhangYLow expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resectionBMC Cancer201818146029690860
- SingalAGEl-SeragHBHepatocellular carcinoma from epidemiology to prevention: translating knowledge into practiceClin Gastroenterol Hepatol201513122140215126284591
- Boriack-SjodinPARibichSCopelandRARNA-modifying proteins as anticancer drug targetsNat Rev Drug Discov201817643545329773918
- YouJSJonesPACancer genetics and epigenetics: two sides of the same coin?Cancer Cell201222192022789535
- LairdPWThe power and the promise of DNA methylation markersNat Rev Cancer20033425326612671664
- KochAJoostenSCFengZAnalysis of DNA methylation in cancer: location revisitedNat Rev Clin Oncol201815745946629666440
- DelpuYCordelierPChoWCTorrisaniJDNA methylation and cancer diagnosisInt J Mol Sci2013147150291505823873296
- DibounIWernischLOrengoCAKoltzenburgMMicroarray analysis after RNA amplification can detect pronounced differences in gene expression using limmaBMC Genomics2006725217029630
- Huang daWShermanBTLempickiRASystematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNat Protoc200941445719131956
- BaderGDHogueCWAn automated method for finding molecular complexes in large protein interaction networksBMC Bioinformatics20034212525261
- RoesslerSJiaHLBudhuAA unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patientsCancer Res20107024102021021221159642
- GalmOHermanJGBaylinSBThe fundamental role of epigenetics in hematopoietic malignanciesBlood Rev200620111316426940
- WeisenbergerDJVelicescuMPreciado-LopezMAIdentification and characterization of alternatively spliced variants of DNA methyltransferase 3a in mammalian cellsGene20022981919912406579
- KochADe MeyerTJeschkeJVan CriekingeWMEXPRESS: visualizing expression, DNA methylation and clinical TCGA dataBMC Genomics20151663626306699
- WangZTengDLiYHuZLiuLZhengHA six-gene-based prognostic signature for hepatocellular carcinoma overall survival predictionLife Sci2018203839129678742
- BruixJLlovetJMMajor achievements in hepatocellular carcinomaLancet2009373966461461619231618
- WongKFXuZChenJLeeNPLukJMCirculating markers for prognosis of hepatocellular carcinomaExpert Opin Med Diagn20137431932923642136
- ChenHSunXGeWQianYBaiRZhengSA seven-gene signature predicts overall survival of patients with colorectal cancerOncotarget2017856950549506529221110
- XieXJLiuPCaiCDZhuangYRZhangLThe generation and validation of a 20-Genes model influencing the prognosis of colorectal cancer20171181136753685
- LiuWTWangYZhangJA novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinomaCancer Lett2018425435329608985
- GyőrffyBSurowiakPBudcziesJLánczkyAOnline survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancerPLoS One2013812e8224124367507
- LuGChangJTLiuZChenYLiMZhuJJPhospholipase C Beta 1: a candidate signature gene for proneural subtype high-grade gliomaMol Neurobiol20165396511652526614510
- ZhouLDuYKongLZhangXChenQIdentification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysisOnco Targets Ther2018111861186929670361
- LiBFengWLuoODevelopment and validation of a three-gene prognostic signature for patients with hepatocellular carcinomaSci Rep201771551728717245
- KannanLRamosMReAPublic data and open source tools for multi-assay genomic investigation of diseaseBrief Bioinform201617460361526463000
- YingHYGongCJFengYJingDDLuLGSerine protease inhibitor Kazal type 1 (SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathwayJ Dig Dis201718634935828544403
- MarshallALukkMKutterCDaviesSAlexanderGOdomDTGlobal gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma markerPLoS One201383e5945923527199
- FuBMengWZengXZhaoHLiuWTXNRD1 is an unfavorable prognostic factor for patients with hepatocellular carcinomaBiomed Res Int20172017469816728536696
- RieswijkLClaessenSMBekersOAflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinomaToxicology20163503523139
- CookeALMorrisJMelchiorJTA thumbwheel mechanism for APOA1 activation of LCAT activity in HDLJ Lipid Res20185971244125529773713
- RussellMRGrahamCD’AmatoAA combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumoursBr J Cancer2017117566667428664912
- SubbaiahPVLiuMWittTRImpaired cholesterol esterification in the plasma in patients with breast cancerLipids19973221571629075205
- NassKJvan den BergEHGruppenEGDullaartRPFPlasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver diseaseEur J Clin Invest2018489e1298829947103
- HuangSSunCHouYA comprehensive bioinformatics analysis on multiple Gene Expression Omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitisSci Rep201881763029769552
- ChenSYangZWilkinsonAWThe PZP domain of AF10 senses unmodified H3K27 to regulate DOT1L-mediated methylation of H3K79Mol Cell201560231932726439302
- KleinBJMuthurajanUMLalondeMEBivalent interaction of the PZP domain of BRPF1 with the nucleosome impacts chromatin dynamics and acetylationNucleic Acids Res201644147248426626149